Don't let it happen!
Don't let this CEO and the wallstreet cronies and top 10 major institutions force you out.
If there are any old-time dndn shareholders still here, go to the shareholder meeting this June and express your concerns in greater frustration than last years shareholder meeting.
Given the stock price action being controlled by institutional shorts and given this CEO's compensity to underpromise, generate some uncertainty and to NOW TO SUDDENLY SAY YESTERDAY THAT COMPETITION IS NOW AFFECTING PROVENGE SALES IS REPREHENSIBLE!
All this CEO JJ has done is kept sales flat since he came on board...which is wallstreets bidding.
All this CEO JJ has to do is move from treating 860 patients to 1076 ($100M).
We're just talking about a move of treating an additional 200 patients per quarter to hit $100M in revenue.
It's obvious that CEO JJ want's to get his hands around this enormous market of mCRPC in the U.S. and identify all potential patients... and I can understand that.
But to allow wallstreet institutions to continue massively short is unforgivable.
Don't let him and wallstreet force you out of this company.
Buy Hold Long & Strong
Sentiment: Strong Buy
Ummm...duh! This was obvious at $11 and that's why I said sell at that level. Stock then dipped into the 3's.
"NOW TO SUDDENLY SAY YESTERDAY THAT COMPETITION IS NOW AFFECTING PROVENGE SALES IS REPREHENSIBLE!"
Bass, I'm another usually-silent long-term holder; been here since '09- I made a boatload at the top and caught the knife at 9. We've seen 'em come and go, but the fundamental story remains the same. No one can predict the future, but this is still as good a spec stock as any, AND the short interest and the FUD all but ensure that IF it pops it'll be a big pop- again. As for Johnson, I think the common reaction- seen on countless message boards- is to blame the CEO for ignoring the stock price. I think that in biopharma, especially when you're trying to grow a company, it's best to ignore the stock price (and thus the shareholders) and focus on what's important. Now, if in a couple years we see no label expansion,
Ignore this short belongsinamuseum. Read his history.
I agree that this CEO should be ousted for catering to wallstreet interests. He has taken the stock from $17 to where its at today, by allowing tute shorts to massively short his company while they accumulate millions. Even the HLF CEO has the balls to defend his company from a hedge fund led short attack!
If anyone remembers that dndn bear raid of 2009 where the stock dropped from $20 to $7 before recovering, well the same thing happened when Gold pulled guidance in August 2011.
I AGREE THAT THIS WAS A MAJOR SHORT BEAR RAID AS SHORT INTEREST BLEW UP FROM 14 MILLION TO 18 MILLION. And that 18 million is only a data point in time. It may have taken more than that to pull a stock drop from $36 to $10 on that Aug 3 fateful day. your words, not mine bass
This Icahn CEO crony John Johnson is to blame...period!
He took the stock from $17 down to $5
end of story
Let's give this CEO some more time bass.
He just finished building out his own sales team and setting up additional infrastructure to support all the oncologists and urologists across the country. I think nearterm, we're going to see a substantial move above what they've been treating for the last 4 quarters.
More time Iamthereal_bass...(lol)?
Are you kdding? I've been in dndn forever and never sold. To have a change in negotiators at the CEO level where this CEO doesn't defend his company against a silent deadly massive short attack...? Well, I think he's weak.
Sentiment: Strong Buy